Cell-Based Fluorescence Resonance Energy Transfer (Fret) Assays For Clostridial Toxins

Patent No. EP1543329 (titled "Cell-Based Fluorescence Resonance Energy Transfer (Fret) Assays For Clostridial Toxins") was filed by Allergan on Sep 4, 2003. The application was issued on Aug 3, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IPSEN PHARMAMay 3, 2017CABINET PLASSERAUD
NOTARBARTOLO & GERVASIDec 23, 2016PALLINI GERVASI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1543329

ALLERGAN
Application Number
EP03774466A
Filing Date
Sep 4, 2003
Status
Revoked
Feb 22, 2019
Publication Date
Aug 3, 2016